Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

Fluicell

11.80 SEK

-4.07 %

Less than 1K followers

FLUI

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Quarter data

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Fluicell

Q3/24Q4/242024Q1/25Q2/25Q3/25Q4/252025
Revenue0.50.51.90.20.71.23.86.0
EBITDA-0.9-1.7-15.4-2.5-2.7-2.7-0.0-8.0
EBIT-1.0-1.8-15.8-2.6-2.8-2.8-0.1-8.4
EBIT-%-198.1 %-351.9 %-851.6 %-1,147.8 %-402.9 %-229.9 %-2.5 %-139.9 %
Profit before taxes-1.1-1.4-15.5-2.7-2.9-2.90.1-8.3
Net income-1.1-1.4-15.5-2.7-2.9-2.90.1-8.3
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.